ID CUTI1_FUSVN Reviewed; 230 AA. AC P00590; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 21-JUL-1986, sequence version 1. DT 27-MAR-2024, entry version 141. DE RecName: Full=Cutinase 1; DE EC=3.1.1.74 {ECO:0000255|PROSITE-ProRule:PRU10108, ECO:0000255|PROSITE-ProRule:PRU10109, ECO:0000269|PubMed:18658138, ECO:0000305|PubMed:19810726, ECO:0000305|PubMed:8286366, ECO:0000305|PubMed:8555209}; DE AltName: Full=Cutin hydrolase 1; DE Flags: Precursor; GN Name=CUT1; Synonyms=CUTA; OS Fusarium vanettenii (Neocosmospora pisi). OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes; OC Hypocreomycetidae; Hypocreales; Nectriaceae; Fusarium; OC Fusarium solani species complex. OX NCBI_TaxID=2747968; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 57-94; 113-142 AND RP 183-192. RC STRAIN=T-8; RX PubMed=16593482; DOI=10.1073/pnas.81.13.3939; RA Soliday C.L., Flurkey W.H., Okita T.W., Kolattukudy P.E.; RT "Cloning and structure determination of cDNA for cutinase, an enzyme RT involved in fungal penetration of plants."; RL Proc. Natl. Acad. Sci. U.S.A. 81:3939-3943(1984). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2703464; DOI=10.1128/jb.171.4.1942-1951.1989; RA Soliday C.L., Dickman M.B., Kolattukudy P.E.; RT "Structure of the cutinase gene and detection of promoter activity in the RT 5'-flanking region by fungal transformation."; RL J. Bacteriol. 171:1942-1951(1989). RN [3] RP GLUCURONIC-ACID BINDING AT GLY-32, AND GLYCOSYLATION. RX PubMed=7398618; DOI=10.1111/j.1432-1033.1980.tb04580.x; RA Lin T.-S., Kolattukudy P.E.; RT "Structural studies on cutinase, a glycoprotein containing novel amino RT acids and glucuronic acid amide at the N terminus."; RL Eur. J. Biochem. 106:341-351(1980). RN [4] RP FUNCTION. RX DOI=10.1038/342446a0; RA Dickman M.B., Podila G.K., Kolattukudy P.E.; RT "Insertion of cutinase gene into a wound pathogen enables it to infect RT intact host."; RL Nature 342:446-448(1989). RN [5] RP BIOTECHNOLOGY. RX DOI=10.1002/pola.20684; RA Silva C., Carneiro F., O'Neill A., Fonseca L.P., Cabral J.S.M., Guebitz G., RA Cavaco-Paulo A.; RT "Cutinase--A new tool for biomodification of synthetic fibers."; RL J. Polym. Sci. 128:849-857(2005). RN [6] RP BIOTECHNOLOGY, AND MUTAGENESIS OF LEU-97; ASN-100; LEU-198; VAL-200 AND RP LEU-205. RX PubMed=17306400; DOI=10.1016/j.jbiotec.2006.12.028; RA Araujo R., Silva C., O'Neill A., Micaelo N., Guebitz G., Soares C.M., RA Casal M., Cavaco-Paulo A.; RT "Tailoring cutinase activity towards polyethylene terephthalate and RT polyamide 6,6 fibers."; RL J. Biotechnol. 128:849-857(2007). RN [7] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND RP BIOTECHNOLOGY. RX PubMed=18658138; DOI=10.1074/jbc.m800848200; RA Chen S., Tong X., Woodard R.W., Du G., Wu J., Chen J.; RT "Identification and characterization of bacterial cutinase."; RL J. Biol. Chem. 283:25854-25862(2008). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=19810726; DOI=10.1021/ja9046697; RA Liu Z., Gosser Y., Baker P.J., Ravee Y., Lu Z., Alemu G., Li H., RA Butterfoss G.L., Kong X.P., Gross R., Montclare J.K.; RT "Structural and functional studies of Aspergillus oryzae cutinase: enhanced RT thermostability and hydrolytic activity of synthetic ester and polyester RT degradation."; RL J. Am. Chem. Soc. 131:15711-15716(2009). RN [9] RP ACTIVITY REGULATION, AND BIOTECHNOLOGY. RX PubMed=25219509; DOI=10.1016/j.jmb.2014.09.003; RA Roussel A., Amara S., Nyyssola A., Mateos-Diaz E., Blangy S., Kontkanen H., RA Westerholm-Parvinen A., Carriere F., Cambillau C.; RT "A Cutinase from Trichoderma reesei with a lid-covered active site and RT kinetic properties of true lipases."; RL J. Mol. Biol. 426:3757-3772(2014). RN [10] {ECO:0007744|PDB:1CUS} RP X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 31-230, ACTIVE SITE, AND RP DISULFIDE BONDS. RX PubMed=1560844; DOI=10.1038/356615a0; RA Martinez C., de Geus P., Lauwereys M., Matthyssens G., Cambillau C.; RT "Fusarium solani cutinase is a lipolytic enzyme with a catalytic serine RT accessible to solvent."; RL Nature 356:615-618(1992). RN [11] {ECO:0007744|PDB:2CUT} RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 31-228 IN COMPLEX WITH INHIBITOR RP PARAOXON, FUNCTION, CATALYTIC ACTIVITY, AND DISULFIDE BONDS. RX PubMed=8286366; DOI=10.1021/bi00167a011; RA Martinez C., Nicolas A., van Tilbeurgh H., Egloff M.-P., Cudrey C., RA Verger R., Cambillau C.; RT "Cutinase, a lipolytic enzyme with a preformed oxyanion hole."; RL Biochemistry 33:83-89(1994). RN [12] {ECO:0007744|PDB:1XZB, ECO:0007744|PDB:1XZC} RP X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 17-230, AND DISULFIDE BONDS. RA Longhi S., Martinez C., Nicolas A., Cambillau C.; RT "Core Accessibility of Fusarium Solani Pisi Cutinase Explored by Means of RT Hg Derivatives of the S129C Mutant."; RL Submitted (NOV-1995) to the PDB data bank. RN [13] {ECO:0007744|PDB:1FFA, ECO:0007744|PDB:1FFB, ECO:0007744|PDB:1FFC, ECO:0007744|PDB:1FFD, ECO:0007744|PDB:1FFE} RP X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 17-230, FUNCTION, CATALYTIC RP ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, DISULFIDE BONDS, AND MUTAGENESIS RP OF SER-58 AND ASN-100. RX PubMed=8555209; DOI=10.1021/bi9515578; RA Nicolas A., Egmond M., Verrips C.T., de Vlieg J., Longhi S., Cambillau C., RA Martinez C.; RT "Contribution of cutinase serine 42 side chain to the stabilization of the RT oxyanion transition state."; RL Biochemistry 35:398-410(1996). RN [14] {ECO:0007744|PDB:1CUA, ECO:0007744|PDB:1CUB, ECO:0007744|PDB:1CUC, ECO:0007744|PDB:1CUD, ECO:0007744|PDB:1CUE, ECO:0007744|PDB:1CUF, ECO:0007744|PDB:1CUG, ECO:0007744|PDB:1CUH, ECO:0007744|PDB:1CUI, ECO:0007744|PDB:1CUJ, ECO:0007744|PDB:1CUU} RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 17-230 OF MUTANT CYS-136, AND RP DISULFIDE BONDS. RX PubMed=8990497; RX DOI=10.1002/(sici)1097-0134(199612)26:4<442::aid-prot5>3.0.co;2-d; RA Longhi S., Nicolas A., Creveld L., Egmond M., Verrips C.T., de Vlieg J., RA Martinez C., Cambillau C.; RT "Dynamics of Fusarium solani cutinase investigated through structural RT comparison among different crystal forms of its variants."; RL Proteins 26:442-458(1996). RN [15] {ECO:0007744|PDB:1AGY, ECO:0007744|PDB:1CEX} RP X-RAY CRYSTALLOGRAPHY (1.00 ANGSTROMS) OF 17-230, ACTIVE SITE, AND RP DISULFIDE BONDS. RX PubMed=9175860; DOI=10.1006/jmbi.1997.1000; RA Longhi S., Czjzek M., Lamzin V., Nicolas A., Cambillau C.; RT "Atomic resolution (1.0 A) crystal structure of Fusarium solani cutinase: RT stereochemical analysis."; RL J. Mol. Biol. 268:779-799(1997). RN [16] {ECO:0007744|PDB:1OXM} RP X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 17-230 IN COMPLEX WITH A RP SUBSTRATE ANALOG, AND DISULFIDE BONDS. RX PubMed=9041628; DOI=10.1002/pro.5560060202; RA Longhi S., Mannesse M., Verheij H.M., De Haas G.H., Egmond M., RA Knoops-Mouthuy E., Cambillau C.; RT "Crystal structure of cutinase covalently inhibited by a triglyceride RT analogue."; RL Protein Sci. 6:275-286(1997). RN [17] RP STRUCTURE BY NMR. RX PubMed=9385640; DOI=10.1002/pro.5560061111; RA Prompers J.J., Groenewegen A., van Schaik R.C., Pepermans H.A.M., RA Hilbers C.W.; RT "1H, 13C, and 15N resonance assignments of Fusarium solani pisi cutinase RT and preliminary features of the structure in solution."; RL Protein Sci. 6:2375-2384(1997). RN [18] {ECO:0007744|PDB:3EF3, ECO:0007744|PDB:3ESA, ECO:0007744|PDB:3ESB, ECO:0007744|PDB:3ESC, ECO:0007744|PDB:3ESD} RP X-RAY CRYSTALLOGRAPHY (1.20 ANGSTROMS) OF 17-230, AND DISULFIDE BONDS. RX PubMed=19219875; DOI=10.1002/chem.200801995; RA Rutten L., Wieczorek B., Mannie J.P., Kruithof C.A., Dijkstra H.P., RA Egmond M.R., Lutz M., Klein Gebbink R.J., Gros P., van Koten G.; RT "Solid-state structural characterization of cutinase-ECE-pincer-metal RT hybrids."; RL Chemistry 15:4270-4280(2009). RN [19] {ECO:0007744|PDB:3QPA, ECO:0007744|PDB:3QPC} RP X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 32-228, AND DISULFIDE BONDS. RA Lu A., Gosser Y., Montclare J.K., Liu Z., Kong X.; RT "Structure of Fusarium Solani Cutinase expressed in Pichia pastoris."; RL Submitted (FEB-2011) to the PDB data bank. CC -!- FUNCTION: Catalyzes the hydrolysis of complex carboxylic polyesters CC found in the cell wall of plants (PubMed:18658138, PubMed:8286366, CC PubMed:8555209, PubMed:19810726). Degrades cutin, a macromolecule that CC forms the structure of the plant cuticle (PubMed:18658138, CC PubMed:8286366, PubMed:8555209, PubMed:19810726). Allows pathogenic CC fungi to penetrate through the cuticular barrier into the host plant CC during the initial stage of fungal infection (Ref.4). CC {ECO:0000269|PubMed:18658138, ECO:0000269|PubMed:19810726, CC ECO:0000269|PubMed:8286366, ECO:0000269|PubMed:8555209, CC ECO:0000269|Ref.4}. CC -!- CATALYTIC ACTIVITY: CC Reaction=cutin + H2O = cutin monomers.; EC=3.1.1.74; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10108, ECO:0000255|PROSITE- CC ProRule:PRU10109, ECO:0000269|PubMed:18658138, CC ECO:0000305|PubMed:19810726, ECO:0000305|PubMed:8286366, CC ECO:0000305|PubMed:8555209}; CC -!- ACTIVITY REGULATION: Inhibited by n-undecyl phosphonate (C11Y4) CC (PubMed:25219509). Inhibited by paraoxon (PubMed:8286366, CC PubMed:25219509). {ECO:0000269|PubMed:25219509, CC ECO:0000269|PubMed:8286366}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.67 uM for p-nitrophenyl acetate (at pH 7.5) CC {ECO:0000269|PubMed:19810726}; CC KM=1.26 uM for p-nitrophenyl butyrate (at pH 7.5) CC {ECO:0000269|PubMed:19810726}; CC KM=0.68 mM for p-nitrophenyl butyrate (at pH 9 and 30 degrees CC Celsius) {ECO:0000269|PubMed:8555209}; CC KM=1.48 uM for p-nitrophenyl valerate (at pH 7.5) CC {ECO:0000269|PubMed:19810726}; CC KM=1.5 uM for p-nitrophenyl hexanoate (at pH 7.5) CC {ECO:0000269|PubMed:19810726}; CC Note=kcat is 1800 sec(-1) with p-nitrophenyl butyrate as substrate CC (at pH 9 and 30 degrees Celsius). {ECO:0000269|PubMed:8555209}; CC pH dependence: CC Optimum pH is 8. {ECO:0000269|PubMed:18658138}; CC Temperature dependence: CC Optimum temperature is below 30 degrees Celsius (PubMed:19810726). CC Optimum temperature is 30-40 degrees Celsius (PubMed:18658138). CC {ECO:0000269|PubMed:18658138, ECO:0000269|PubMed:19810726}; CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P11373}. CC -!- PTM: The 2 disulfide bonds play a critical role in holding the CC catalytic residues in juxta-position; reduction of the disulfide CC bridges results in the complete inactivation of the enzyme. CC {ECO:0000250|UniProtKB:P11373}. CC -!- PTM: O-glycosylated; contains one mole each of mannose, arabinose, N- CC acetylglucosamine, and glucuronic acid. {ECO:0000269|PubMed:7398618}. CC -!- BIOTECHNOLOGY: May have promising applications in chemical and textile CC industries as it is capable of hydrolyzing a variety of substrates CC including soluble esters and insoluble triglycerides (PubMed:18658138, CC PubMed:25219509). Can hydrolyze and thus modulate the surface CC properties of synthetic fibers such as the plastic poly(ethylene CC terephthalate) (PET), or the textile fibers polyamide 6,6, polyester CC and acrylic (Ref.5, PubMed:17306400). {ECO:0000269|PubMed:17306400, CC ECO:0000269|PubMed:18658138, ECO:0000269|PubMed:25219509, CC ECO:0000269|Ref.5}. CC -!- SIMILARITY: Belongs to the cutinase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; K02640; AAA33334.1; -; mRNA. DR EMBL; M29759; AAA33335.1; -; Genomic_DNA. DR PIR; A32836; UVFUS. DR PDB; 1AGY; X-ray; 1.15 A; A=31-230. DR PDB; 1CEX; X-ray; 1.00 A; A=17-230. DR PDB; 1CUA; X-ray; 1.80 A; A=17-230. DR PDB; 1CUB; X-ray; 1.75 A; A=17-230. DR PDB; 1CUC; X-ray; 1.75 A; A=17-230. DR PDB; 1CUD; X-ray; 2.70 A; A/B/C=17-230. DR PDB; 1CUE; X-ray; 2.10 A; A=33-229. DR PDB; 1CUF; X-ray; 1.75 A; A=17-230. DR PDB; 1CUG; X-ray; 1.75 A; A=17-230. DR PDB; 1CUH; X-ray; 1.75 A; A=17-230. DR PDB; 1CUI; X-ray; 2.50 A; A=17-230. DR PDB; 1CUJ; X-ray; 1.60 A; A=17-230. DR PDB; 1CUS; X-ray; 1.25 A; A=31-230. DR PDB; 1CUU; X-ray; 1.69 A; A=17-230. DR PDB; 1CUV; X-ray; 2.01 A; A=17-230. DR PDB; 1CUW; X-ray; 2.70 A; A/B=17-230. DR PDB; 1CUX; X-ray; 1.75 A; A=17-230. DR PDB; 1CUY; X-ray; 1.69 A; A=17-230. DR PDB; 1CUZ; X-ray; 2.10 A; A=17-230. DR PDB; 1FFA; X-ray; 1.69 A; A=17-230. DR PDB; 1FFB; X-ray; 1.75 A; A=17-230. DR PDB; 1FFC; X-ray; 1.75 A; A=17-230. DR PDB; 1FFD; X-ray; 1.69 A; A=17-230. DR PDB; 1FFE; X-ray; 1.69 A; A=17-230. DR PDB; 1OXM; X-ray; 2.30 A; A/B=17-230. DR PDB; 1XZA; X-ray; 1.80 A; A=17-230. DR PDB; 1XZB; X-ray; 1.75 A; A=17-230. DR PDB; 1XZC; X-ray; 1.75 A; A=17-230. DR PDB; 1XZD; X-ray; 2.70 A; A=17-228. DR PDB; 1XZE; X-ray; 1.75 A; A=17-230. DR PDB; 1XZF; X-ray; 1.69 A; A=17-230. DR PDB; 1XZG; X-ray; 1.69 A; A=17-230. DR PDB; 1XZH; X-ray; 1.69 A; A=17-230. DR PDB; 1XZI; X-ray; 1.69 A; A=17-230. DR PDB; 1XZJ; X-ray; 1.69 A; A=17-230. DR PDB; 1XZK; X-ray; 2.01 A; A/B=17-230. DR PDB; 1XZL; X-ray; 1.69 A; A=17-230. DR PDB; 1XZM; X-ray; 1.75 A; A=17-230. DR PDB; 2CUT; X-ray; 1.90 A; A=31-228. DR PDB; 3EF3; X-ray; 1.50 A; A=17-230. DR PDB; 3ESA; X-ray; 2.00 A; A/B=17-230. DR PDB; 3ESB; X-ray; 2.30 A; A=17-230. DR PDB; 3ESC; X-ray; 1.20 A; A=17-230. DR PDB; 3ESD; X-ray; 1.22 A; A=17-230. DR PDB; 3QPA; X-ray; 0.85 A; A=32-228. DR PDB; 3QPC; X-ray; 0.98 A; A=32-228. DR PDBsum; 1AGY; -. DR PDBsum; 1CEX; -. DR PDBsum; 1CUA; -. DR PDBsum; 1CUB; -. DR PDBsum; 1CUC; -. DR PDBsum; 1CUD; -. DR PDBsum; 1CUE; -. DR PDBsum; 1CUF; -. DR PDBsum; 1CUG; -. DR PDBsum; 1CUH; -. DR PDBsum; 1CUI; -. DR PDBsum; 1CUJ; -. DR PDBsum; 1CUS; -. DR PDBsum; 1CUU; -. DR PDBsum; 1CUV; -. DR PDBsum; 1CUW; -. DR PDBsum; 1CUX; -. DR PDBsum; 1CUY; -. DR PDBsum; 1CUZ; -. DR PDBsum; 1FFA; -. DR PDBsum; 1FFB; -. DR PDBsum; 1FFC; -. DR PDBsum; 1FFD; -. DR PDBsum; 1FFE; -. DR PDBsum; 1OXM; -. DR PDBsum; 1XZA; -. DR PDBsum; 1XZB; -. DR PDBsum; 1XZC; -. DR PDBsum; 1XZD; -. DR PDBsum; 1XZE; -. DR PDBsum; 1XZF; -. DR PDBsum; 1XZG; -. DR PDBsum; 1XZH; -. DR PDBsum; 1XZI; -. DR PDBsum; 1XZJ; -. DR PDBsum; 1XZK; -. DR PDBsum; 1XZL; -. DR PDBsum; 1XZM; -. DR PDBsum; 2CUT; -. DR PDBsum; 3EF3; -. DR PDBsum; 3ESA; -. DR PDBsum; 3ESB; -. DR PDBsum; 3ESC; -. DR PDBsum; 3ESD; -. DR PDBsum; 3QPA; -. DR PDBsum; 3QPC; -. DR AlphaFoldDB; P00590; -. DR BMRB; P00590; -. DR SMR; P00590; -. DR ChEMBL; CHEMBL2176862; -. DR ESTHER; fusso-cutas; Cutinase. DR GlyConnect; 116; 2 O-Linked glycans. DR GlyCosmos; P00590; No site information, 4 glycans. DR VEuPathDB; FungiDB:NECHADRAFT_81019; -. DR BRENDA; 3.1.1.74; 8196. DR SABIO-RK; P00590; -. DR EvolutionaryTrace; P00590; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0050525; F:cutinase activity; IDA:UniProtKB. DR Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1. DR InterPro; IPR029058; AB_hydrolase. DR InterPro; IPR000675; Cutinase/axe. DR InterPro; IPR043580; CUTINASE_1. DR InterPro; IPR043579; CUTINASE_2. DR InterPro; IPR011150; Cutinase_monf. DR PANTHER; PTHR48250:SF3; CUTINASE 1-RELATED; 1. DR PANTHER; PTHR48250; CUTINASE 2-RELATED; 1. DR Pfam; PF01083; Cutinase; 1. DR PRINTS; PR00129; CUTINASE. DR SMART; SM01110; Cutinase; 1. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. DR PROSITE; PS00155; CUTINASE_1; 1. DR PROSITE; PS00931; CUTINASE_2; 1. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Disulfide bond; Glycoprotein; KW Hydrolase; Secreted; Serine esterase; Signal; Virulence. FT SIGNAL 1..16 FT /evidence="ECO:0000255" FT PROPEP 17..31 FT /evidence="ECO:0000305|PubMed:16593482" FT /id="PRO_0000455280" FT CHAIN 32..230 FT /note="Cutinase 1" FT /id="PRO_0000006440" FT ACT_SITE 136 FT /note="Nucleophile" FT /evidence="ECO:0000269|PubMed:1560844, FT ECO:0007744|PDB:1AGY" FT ACT_SITE 191 FT /evidence="ECO:0000269|PubMed:1560844, FT ECO:0007744|PDB:1AGY" FT ACT_SITE 204 FT /note="Proton donor/acceptor" FT /evidence="ECO:0000269|PubMed:1560844, FT ECO:0007744|PDB:1AGY" FT SITE 58 FT /note="Transition state stabilizer" FT /evidence="ECO:0000269|PubMed:1560844, FT ECO:0000269|PubMed:8286366, ECO:0000269|PubMed:8555209, FT ECO:0000269|PubMed:9041628, ECO:0007744|PDB:1AGY, FT ECO:0007744|PDB:1FFE, ECO:0007744|PDB:1OXM, FT ECO:0007744|PDB:2CUT" FT SITE 137 FT /note="Transition state stabilizer" FT /evidence="ECO:0000269|PubMed:1560844, FT ECO:0000269|PubMed:8286366, ECO:0000269|PubMed:9041628, FT ECO:0007744|PDB:1AGY, ECO:0007744|PDB:1OXM, FT ECO:0007744|PDB:2CUT" FT MOD_RES 32 FT /note="N-D-glucuronoyl glycine" FT /evidence="ECO:0000269|PubMed:7398618" FT DISULFID 47..125 FT /evidence="ECO:0000269|PubMed:1560844, FT ECO:0000269|PubMed:19219875, ECO:0000269|PubMed:8286366, FT ECO:0000269|PubMed:8555209, ECO:0000269|PubMed:8990497, FT ECO:0000269|PubMed:9041628, ECO:0000269|PubMed:9175860, FT ECO:0000269|Ref.12, ECO:0007744|PDB:1AGY, FT ECO:0007744|PDB:1CEX, ECO:0007744|PDB:1CUA, FT ECO:0007744|PDB:1CUB, ECO:0007744|PDB:1CUC, FT ECO:0007744|PDB:1CUD, ECO:0007744|PDB:1CUE, FT ECO:0007744|PDB:1CUF, ECO:0007744|PDB:1CUG, FT ECO:0007744|PDB:1CUH, ECO:0007744|PDB:1CUI, FT ECO:0007744|PDB:1CUJ, ECO:0007744|PDB:1CUS, FT ECO:0007744|PDB:1CUU, ECO:0007744|PDB:1CUV, FT ECO:0007744|PDB:1CUW, ECO:0007744|PDB:1CUX, FT ECO:0007744|PDB:1CUY, ECO:0007744|PDB:1CUZ, FT ECO:0007744|PDB:1FFA, ECO:0007744|PDB:1FFB, FT ECO:0007744|PDB:1FFC, ECO:0007744|PDB:1FFD, FT ECO:0007744|PDB:1FFE, ECO:0007744|PDB:1OXM, FT ECO:0007744|PDB:1XZA, ECO:0007744|PDB:1XZB, FT ECO:0007744|PDB:1XZC, ECO:0007744|PDB:1XZD, FT ECO:0007744|PDB:1XZE, ECO:0007744|PDB:1XZF, FT ECO:0007744|PDB:1XZG, ECO:0007744|PDB:1XZH, FT ECO:0007744|PDB:1XZI, ECO:0007744|PDB:1XZJ, FT ECO:0007744|PDB:1XZK, ECO:0007744|PDB:1XZL, FT ECO:0007744|PDB:1XZM, ECO:0007744|PDB:2CUT, FT ECO:0007744|PDB:3EF3, ECO:0007744|PDB:3ESA, FT ECO:0007744|PDB:3ESB, ECO:0007744|PDB:3ESC, FT ECO:0007744|PDB:3ESD, ECO:0007744|PDB:3QPA, FT ECO:0007744|PDB:3QPC" FT DISULFID 187..194 FT /evidence="ECO:0000269|PubMed:1560844, FT ECO:0000269|PubMed:19219875, ECO:0000269|PubMed:8286366, FT ECO:0000269|PubMed:8555209, ECO:0000269|PubMed:8990497, FT ECO:0000269|PubMed:9041628, ECO:0000269|PubMed:9175860, FT ECO:0000269|Ref.12, ECO:0007744|PDB:1AGY, FT ECO:0007744|PDB:1CEX, ECO:0007744|PDB:1CUA, FT ECO:0007744|PDB:1CUB, ECO:0007744|PDB:1CUC, FT ECO:0007744|PDB:1CUD, ECO:0007744|PDB:1CUE, FT ECO:0007744|PDB:1CUF, ECO:0007744|PDB:1CUG, FT ECO:0007744|PDB:1CUH, ECO:0007744|PDB:1CUI, FT ECO:0007744|PDB:1CUJ, ECO:0007744|PDB:1CUS, FT ECO:0007744|PDB:1CUU, ECO:0007744|PDB:1CUV, FT ECO:0007744|PDB:1CUW, ECO:0007744|PDB:1CUX, FT ECO:0007744|PDB:1CUY, ECO:0007744|PDB:1CUZ, FT ECO:0007744|PDB:1FFA, ECO:0007744|PDB:1FFB, FT ECO:0007744|PDB:1FFC, ECO:0007744|PDB:1FFD, FT ECO:0007744|PDB:1FFE, ECO:0007744|PDB:1OXM, FT ECO:0007744|PDB:1XZA, ECO:0007744|PDB:1XZB, FT ECO:0007744|PDB:1XZC, ECO:0007744|PDB:1XZD, FT ECO:0007744|PDB:1XZE, ECO:0007744|PDB:1XZF, FT ECO:0007744|PDB:1XZG, ECO:0007744|PDB:1XZH, FT ECO:0007744|PDB:1XZI, ECO:0007744|PDB:1XZJ, FT ECO:0007744|PDB:1XZK, ECO:0007744|PDB:1XZL, FT ECO:0007744|PDB:1XZM, ECO:0007744|PDB:2CUT, FT ECO:0007744|PDB:3EF3, ECO:0007744|PDB:3ESA, FT ECO:0007744|PDB:3ESB, ECO:0007744|PDB:3ESC, FT ECO:0007744|PDB:3ESD, ECO:0007744|PDB:3QPA, FT ECO:0007744|PDB:3QPC" FT MUTAGEN 58 FT /note="S->A: Severely decreases activity on p-nitrophenyl FT butyrate." FT /evidence="ECO:0000269|PubMed:8555209" FT MUTAGEN 97 FT /note="L->A: Increases activity on p-nitrophenyl butyrate." FT /evidence="ECO:0000269|PubMed:17306400" FT MUTAGEN 100 FT /note="N->A,L,D,W: Severely decreases activity on FT p-nitrophenyl butyrate." FT /evidence="ECO:0000269|PubMed:17306400, FT ECO:0000269|PubMed:8555209" FT MUTAGEN 100 FT /note="N->A: Increases activity on poly(ethylene FT terephthalate) (PET) and decreases activity on polyamide FT 6,6." FT /evidence="ECO:0000269|PubMed:17306400" FT MUTAGEN 198 FT /note="L->A: Increases activity on p-nitrophenyl butyrate, FT poly(ethylene terephthalate) (PET) and polyamide 6,6." FT /evidence="ECO:0000269|PubMed:17306400" FT MUTAGEN 200 FT /note="V->A: Increases activity on p-nitrophenyl butyrate FT and poly(ethylene terephthalate) (PET)." FT /evidence="ECO:0000269|PubMed:17306400" FT MUTAGEN 205 FT /note="L->A: Increases activity on p-nitrophenyl butyrate FT and decreases activity on poly(ethylene terephthalate) FT (PET)." FT /evidence="ECO:0000269|PubMed:17306400" FT CONFLICT 48 FT /note="R -> A (in Ref. 2; AAA33335)" FT /evidence="ECO:0000305" FT CONFLICT 94 FT /note="R -> A (in Ref. 2; AAA33335)" FT /evidence="ECO:0000305" FT TURN 38..41 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 44..46 FT /evidence="ECO:0007829|PDB:1CEX" FT STRAND 49..55 FT /evidence="ECO:0007829|PDB:3QPA" FT TURN 62..67 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 68..79 FT /evidence="ECO:0007829|PDB:3QPA" FT TURN 81..83 FT /evidence="ECO:0007829|PDB:3QPA" FT STRAND 84..88 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 97..101 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 108..124 FT /evidence="ECO:0007829|PDB:3QPA" FT STRAND 129..135 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 138..148 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 151..154 FT /evidence="ECO:0007829|PDB:3QPA" FT STRAND 157..164 FT /evidence="ECO:0007829|PDB:3QPA" FT TURN 166..173 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 180..182 FT /evidence="ECO:0007829|PDB:3QPA" FT STRAND 183..186 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 192..195 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 202..205 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 208..212 FT /evidence="ECO:0007829|PDB:3QPA" FT HELIX 214..227 FT /evidence="ECO:0007829|PDB:3QPA" SQ SEQUENCE 230 AA; 23982 MW; 7253ACAA657AD1AB CRC64; MKFFALTTLL AATASALPTS NPAQELEARQ LGRTTRDDLI NGNSASCRDV IFIYARGSTE TGNLGTLGPS IASNLESAFG KDGVWIQGVG GAYRATLGDN ALPRGTSSAA IREMLGLFQQ ANTKCPDATL IAGGYSQGAA LAAASIEDLD SAIRDKIAGT VLFGYTKNLQ NRGRIPNYPA DRTKVFCNTG DLVCTGSLIV AAPHLAYGPD ARGPAPEFLI EKVRAVRGSA //